• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of type 2 diabetes mellitus in children and adolescents.

作者信息

Zuhri-Yafi Mohammad I, Brosnan Patrick G, Hardin Dana S

机构信息

Department of Pediatrics, The University of Texas Medical School-Houston, 77030, USA.

出版信息

J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:541-6.

PMID:12017229
Abstract

OBJECTIVES

To study possible treatment modalities for type 2 diabetes mellitus (T2DM) in children and adolescents.

STUDY DESIGN

We reviewed the medical records of the 25 children and adolescents most recently seen for T2DM in the U.T. Houston diabetes clinics, comparing treatment regimens and results over time. The most common treatment modalities were insulin in combination with oral insulin sensitizing agent (metformin), and metformin alone. End-points evaluated included HbA1c, body weight, and insulin dose.

PATIENTS

Patients ranged in age from 8 to 15 years at diagnosis. The female:male ratio was 1.3:1. Sixty percent of patients were Hispanic. All BMIs were above 85th percentile for age and sex. Acanthosis nigricans was present in 92% of the patients.

RESULTS

Insulin was the only initial treatment in 18 patients (72%), with metformin added and insulin withdrawn as euglycemia developed. Only five of these 18 patients who were started on insulin were completely weaned to metformin monotherapy, and three of those patients later required reintroduction of insulin due to poor control. Metformin did permit reduction of insulin dose in the combination group. Metformin was used as monotherapy in seven patients (28%), but three of them later required another oral hypoglycemic agent. The mean change in HbA1c over the observed period was -2.9% in patients taking insulin only, -2.3% for patients treated with insulin + metformin, and -4.4% in patients who could be treated by metformin alone. HbA1c tended to rise after 2 years of therapy. Few patients sustained weight loss, regardless of treatment regimen.

CONCLUSION

Metformin appears to be an effective medication for the treatment of T2DM in children, but did not seem to be a sufficient long-term monotherapy in our protocol, which required euglycemia for insulin withdrawal. Lifetime management strategies for children with T2DM will probably be as complex as those for adults.

摘要

相似文献

1
Treatment of type 2 diabetes mellitus in children and adolescents.
J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:541-6.
2
Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescents.非裔美国人和加勒比西班牙裔青少年2型糖尿病的临床表现及5年随访
Horm Res. 2003;60(3):121-6. doi: 10.1159/000072523.
3
Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.中国新诊断 2 型糖尿病患者的治疗模式:一项回顾性、纵向数据库研究。
Clin Ther. 2019 Aug;41(8):1440-1452. doi: 10.1016/j.clinthera.2019.05.003. Epub 2019 May 31.
4
Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.多中心、随机、双盲、平行组评估同时使用格列吡嗪/二甲双胍作为磺脲类药物控制不佳的2型糖尿病患者的二线药物治疗。
Clin Ther. 2003 Mar;25(3):890-903. doi: 10.1016/s0149-2918(03)80112-1.
5
Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.七个欧洲国家2型糖尿病患者的血糖控制:糖尿病管理的真实生活有效性和护理模式(RECAP-DM)研究结果
Diabetes Obes Metab. 2008 Jun;10 Suppl 1:8-15. doi: 10.1111/j.1463-1326.2008.00881.x.
6
Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.在意大利真实临床环境中接受利拉鲁肽治疗的大量糖尿病患者中,基线特征与临床结局之间的相关性。
Clin Ther. 2015 Mar 1;37(3):574-84. doi: 10.1016/j.clinthera.2014.11.015. Epub 2015 Jan 24.
7
The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.二甲双胍对伴有空腹高胰岛素血症和2型糖尿病家族史的肥胖青少年体重指数和糖耐量的影响。
Pediatrics. 2001 Apr;107(4):E55. doi: 10.1542/peds.107.4.e55.
8
Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.二甲双胍联合胰岛素治疗超重/肥胖 1 型糖尿病青少年的血糖控制效果:一项随机临床试验。
JAMA. 2015 Dec 1;314(21):2241-50. doi: 10.1001/jama.2015.16174.
9
Management of hyperglycemia in minority children with type 2 diabetes mellitus.
J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:531-40.
10
Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.2型糖尿病中的胰岛素:尽管基于替代终点的评估有限,但仍是一种有用的选择。
Prescrire Int. 2005 Oct;14(79):187-93.

引用本文的文献

1
Exploring the Surge in Paediatric Type 2 Diabetes in an Inner-City London Centre-A Decade-Long Analysis of Incidence, Outcomes, and Transition.探索伦敦市中心儿科2型糖尿病的激增——发病率、转归及病情转变的十年分析
Children (Basel). 2024 Jan 29;11(2):173. doi: 10.3390/children11020173.
2
Effects of once-weekly dulaglutide on juvenile type 2 diabetes mellitus and obesity in Korea: a pilot study.每周一次度拉糖肽对韩国青少年2型糖尿病和肥胖症的影响:一项试点研究。
Ann Pediatr Endocrinol Metab. 2023 Dec;28(4):296-301. doi: 10.6065/apem.2244196.098. Epub 2023 Feb 3.
3
Management of pediatric and adolescent type 2 diabetes.
儿童及青少年2型糖尿病的管理
Int J Pediatr. 2013;2013:972034. doi: 10.1155/2013/972034. Epub 2013 Oct 23.
4
Insulin resistance in type 2 diabetic youth.2 型糖尿病青少年的胰岛素抵抗。
Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):255-62. doi: 10.1097/MED.0b013e3283557cd5.
5
Treatment of type 2 diabetes in youth.青少年2型糖尿病的治疗。
Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S177-83. doi: 10.2337/dc11-s215.
6
Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy.儿童肥胖、胰岛素抵抗和 2 型糖尿病的管理:共识与争议。
Diabetes Metab Syndr Obes. 2009 Nov 27;2:185-202.
7
In search of quality evidence for lifestyle management and glycemic control in children and adolescents with type 2 diabetes: A systematic review.探寻儿童和青少年 2 型糖尿病患者生活方式管理和血糖控制的高质量证据:系统评价。
BMC Pediatr. 2010 Dec 23;10:97. doi: 10.1186/1471-2431-10-97.
8
Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology.小儿非酒精性脂肪性肝病:概述,重点是组织学。
World J Gastroenterol. 2010 Nov 14;16(42):5280-5. doi: 10.3748/wjg.v16.i42.5280.
9
Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents.二甲双胍与生活方式改变对非酒精性脂肪性肝病肥胖青少年的长期影响。
J Obes. 2010;2010. doi: 10.1155/2010/831901. Epub 2010 Feb 9.
10
Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention.小儿非酒精性脂肪肝:生活方式干预的预防和治疗价值。
World J Gastroenterol. 2009 Dec 28;15(48):6017-22. doi: 10.3748/wjg.15.6017.